how does tirzepatide compare to other diabetes medications Understanding the Difference: While both peptides are powerful metabolic tools, their pharmacology is distinct: • (Manjaro): This is a dual agonist targeting GLP-1 (Glucagon-like peptide-1) and GIP (Glucose-dependent insulinotropic Why GLP-1 drugs like semaglutide

Importantly, diabetes remission rates were higher in participants who had undergone BPD-DS, RYGB or sleeve gastrectomy compared with the standard of care [21]

Observational studies have reported improvements in erectile function scores, though more robust research is needed to confirm these benefits

Improved Liver Health Emerging research suggests GLP1 can help reduce liver fat content, making it a promising option for patients with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)

The direct comparison between semaglutide and dulaglutide represents a major strength of this study